Open Access
Access granted
Subscription or Fee Access
No 4 (2009)
- Year: 2009
- Articles: 15
- URL: https://journals.eco-vector.com/2075-3594/issue/view/6291
Articles
SALT INTAKE AND ARTERIAL HYPERTENSION: TIME TO ACT
Abstract
Reduction of sodium content in the diet allows achieving decrease of blood pressure, slowing the progression of target-organ damage and reducing the risk of cardiovascular complications in patients with arterial hypertension. In this regard, limiting consumption of salt should be considered as a preventive measure, the implementation of which is necessary in general population.
Clinical nephrology. 2009;(4):4-5
4-5
9-13
14-18
19-24
CLINICAL AND MOLECULAR PHYSIOLOGY OF OSMOREGULATORY RENAL FUNCTION (ON 200-TH ANNIVERSARY OF F. G. J. HENLE BIRTH)
Abstract
The article is dedicated to the physiological mechanisms of change of urine formation, clinically significant and associated with the function of the Henle loop, water and sodium reabsorption. The molecular mechanisms of regulation violations of urine formation in the clinic of internal diseases, depending on the structures of the brain substance of the kidneys, are analyzed
Clinical nephrology. 2009;(4):25-31
25-31
100-letie "Klinicheskikh lektsiy" G.A. Zakhar'ina
Clinical nephrology. 2009;(4):32-36
32-36
37-44
OSOBENNOSTI REOLOGIChESKIKh SVOYSTV KROVI U BOL'NYKh VOLChANOChNYM NEFRITOM
Abstract
Purpose. Evaluation of rheological characteristics of blood in patients with lupus nephritis.
Materials and methods. The study enrolled 41 patients with systemic lupus erythematosis (SLE) (8 men aged 40 ± 14 years and 33 women aged 37 ± 12 years). Duration of a disease was 120 ± 108 months. Lupus nephritis (LN) was diagnosed in 30 patients. Patients were divided into three groups: those with inactive iLN (iLN), with active LN with urinary syndrome (aLN US) and with active LN with nephrotic syndrome (aLN NS). Patients with aLN have also been divided according to the level of hematuria (HU): the group with moderate HU (less than 10 thousand red blood cells/ml) and the group with severe HU (more than 10 thousand red blood cells/ml). The control group included 26 healthy individuals. Haemorheologial properties of blood - kinetics of spontaneous aggregation and disaggregation of erythrocytes in shear flow and deformation properties of red blood cells - were investigated by optical methods.
Results. Hemorheological changes were observed in all patients with SLE. In general, by comparison with control group, there was an increase in blood viscosity, reduction of deformability of red blood cells, acceleration of their aggregation, as well as increase the typical size of erythrocyte aggregates. Increase of aggregation of red blood cells was in parallel with the rise in blood viscosity. Patients with aLN have low time of red blood aggregation, the maximum size and strength of erythrocyte aggregates and the lowest deformability of red blood cells as compared with entire group of patients with SLE. The blood viscosity was growing in parallel with increase of LN activity. In the aLN group of patients with severe HU, typical size of erythrocyte aggregates was significantly higher than in moderate HU.
Conclusion. SLE patients demonstrated increased blood viscosity due to changes in aggregation and deformation properties of red blood cells, most pronounced in the presence of aLN.
Clinical nephrology. 2009;(4):45-49
45-49
PECULIARITIES OF AMBULATORY BLOOD PRESSURE MONITORING IN PATIENTS WITH ARTERIAL HYPERTENSION STAGES I - II WITH URIC ACID METABOLISM ABNORMALITIES
Abstract
Purpose. Characterization of daily rhythm of blood pressure in patients with arterial hypertension stages I-II with hyperuricosuria/hyperuricaemia.
Materials and methods. 24-hour BP monitoring was performed in 71 patients with arterial hypertension stages I-II not receiving ongoing antihypertensive therapy. In addition to conventional physical examination, all patients were examined for signs of metabolic syndrome, uricemia, and uricosuria.
Results. The insufficient nocturnal decrease of BP was detected in 26% of patients with hyperuricosuria/hyperuricaemia, in 23% - increase of BP in the night, and in 13% - excessive reduction BP level at night. The number of hypertensive patients with night-peacker type of diurnal curve was significantly greater in the group with hyperuricemia/hyperuricosuria compared with those who have no violations of uric acid metabolism (23 and 3% respectively, p <0.01).
Conclusion. Hyperuricemia/hyperuricosuria in arterial hypertension stages I-II predisposes to disorders of the diurnal curve of blood pressure, which characterized mainly by insufficient decrease or further increase of BP at night.
Clinical nephrology. 2009;(4):50-53
50-53
CLINICAL SIGNIFICANCE OF DETERMINATION OR URINARY CONCENTRATION OF ENDOTHELIAL DYSFUNCTION AND FIBROGENESIS MARKERS IN HYPERTENSIVE NEPHROPATHY
Abstract
Purpose. Determination of urinary excretion of molecular markers of endothelial dysfunction and fibrogenesis and evaluation of its relationship with clinical and laboratory signs of hypertensive nephropathy.
Materials and methods. The study enrolled 71 patients with essential arterial hypertension (EAH) stages I-III, according to the classification of Russian Medical Society of Arterial Hypertension, aged 18 to 67 years (mean age, 40.9 ± 14.9 years). Along with physical examination, concentration of transforming growth factor-β1 (TGF-β1) in the urine, vascular endothelial growth factor (VEGF), plasminogen activator inhibitor type 1 (PAI-1) and collagen type IV were examined in all patients.
Results. By comparison with normotensive controls, significant increase in urinary excretion of TGF-β1, VEGF and PAI-1 was observed in patients with EAH. The concentration of these neurotransmitters, as well as type IV collagen in urine was significantly higher in the presence of microalbuminuria.
Conclusion. High concentration of TGF-β 1, VEGF and PAI-1 in the urine may be considered as an early sign of hypertensive nephropathy. Increased urinary excretion of type IV collagen is associated with microalbuminuria and gives evidence in favor of activation of renal fibrogenesis
Clinical nephrology. 2009;(4):54-58
54-58
POTENTIALS OF ANGIOTENSIN II RECEPTOR BLOCKERS IN HALTING THE PROGRESSION OF RENAL TRANSPLANT NEPHROPATHY
Abstract
The article presents pathogenical and clinical justification of administration of angiotensin II receptor blockers, in particular valsartan, in recipients of kidney transplant for the purpose to prevention and inhibition of progression its chronic rejection
Clinical nephrology. 2009;(4):59-62
59-62
63-70
FROM HOPE STUDY TO HOPE-2 AND HOPE-TOO STUDIES: DOES EXISTING PREVENTION STRATEGIES ARE NEED RADICAL IMPROVEMENT?
Abstract
The article discusses results of the HOPE-2 study, which have demonstrated ineffectiveness of folic acid, B6 and B12 vitamins in terms of reducing the risk of cardiovascular complications, and results of HOPE-TOO study, the results of which confirmed the need for the administration of ACE inhibitors, in particular, ramipril, in all patients with high risk of cardiovascular complications. Use of vitamin E in them, on the contrary, it is inappropriate and can be dangerous.
Clinical nephrology. 2009;(4):71-75
71-75
76-77
78-79